Prevalence of interstitial cystitis symptoms in women: A population based study in the primary care office
Prevalence of interstitial cystitis symptoms in women: A population based study in the primary care office
复制标题
DOI：
10.1097/01.ju.0000181203.82693.95
复制
发表时间：
2005-12-01
影响因子：
6.6
通讯作者：
Hazzard, M
中科院分区：
文献类型：
--
作者：
Rosenberg, MT;Hazzard, M
目的：我们估计了在初级保健实践中与女性间质性膀胱炎（IC）相关的泌尿系统症状的患病率，并在美国证实了芬兰人群患病率研究的结果。材料和方法：在2004年1月9日至2004年9月24日期间，使用2项经验证的调查对每名到我们办公室进行常规办公室访视的女性患者进行泌尿系统症状评估，即O 'Leary-Sant（OLS）IC症状和问题指数，以及骨盆疼痛和尿急/尿频（PUF）患者症状量表。结果：在研究组的1，218名妇女中，13名（1.1%）报告了严重的症状和问题（OLS调查中有12名或更多），包括7名（0.6%）符合先前建立的可能IC的标准。在同一人群中，PUF问卷的得分表明，154名妇女（12.6%）可能有IC。结论：根据先前发表的OLS调查使用标准，我们的研究人群中与可能的IC相对应的泌尿系统症状的患病率（575/100，000或0.57%，95% CI 150 - 1，000）与先前报告的0.45%相似。然而，PUF问卷的结果表明，女性IC的患病率实际上可能要高得多（12，600/100，000或12.6%，95% CI 10，700 - 14，500）。我们认为IC在女性中的真实患病率可能介于这两个极端之间。进一步调查这些问卷作为筛选工具IC是必要的。IC在女性中可能比以前报道的更常见。
Purpose: We estimated the prevalence of urinary symptoms related to interstitial cystitis (IC) in women in a primary care practice and confirmed in the United States the results of a Finnish population based prevalence study.Materials and Methods: Every female patient presenting to our office for a routine office visit between January 9, 2004 and September 24, 2004 was evaluated for urinary symptoms using 2 validated surveys, namely the O'Leary-Sant (OLS) IC symptom and problem index, and the Pelvic Pain and Urgency/Frequency (PUF) patient symptom scale.Results: Of the 1,218 women in the study group 13 (1.1%) reported severe symptoms and problems (12 or greater on the OLS survey), including 7 (0.6%) who met previously established criteria for probable IC. In the same population scores on the PUF questionnaire indicated that 154 women (12.6%) likely had IC.Conclusions: Based on previously published criteria for use of the OLS survey the prevalence of urinary symptoms corresponding to probable IC in our study population (575/100,000 or 0.57%, 95% CI 150 to 1,000) was similar to the 0.45% rate previously reported. However, the results of the PUF questionnaire indicated that the prevalence of IC in women may actually be much higher (12,600/100,000 or 12.6%, 95% CI 10,700 to 14,500). We suggest that the true prevalence of IC in women may be somewhere between these 2 extremes. Further investigation of these questionnaires as screening tools for IC is warranted. IC may be more common in women than previously reported.